Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.
about
Overcoming resistance to EGFR tyrosine kinase inhibitors in lung cancer, focusing on non-T790M mechanisms.A case report of EGFR mutant lung adenocarcinoma that acquired resistance to EGFR-tyrosine kinase inhibitors with T790M mutation and epithelial-to-mesenchymal transition.Concurrent epidermal growth factor receptor T790M secondary mutation and epithelial-mesenchymal transition in a lung adenocarcinoma patient with EGFR-TKI drug resistance.Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell lines.Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.The integration of genomics testing and functional proteomics in the era of personalized medicine.Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.
P2860
Q38682189-85527CCF-E6C0-4F2D-AF99-6EF7841B6B01Q41563298-896F19EA-A5E7-4CC2-9EB8-BB31EF9F693EQ47096348-9E9A364A-63D6-4F68-8DEB-77E7D0BAB578Q47141830-0B6CF450-F632-42E5-A618-E9491CA90663Q47726651-EADCE671-3D45-469F-8439-0108F1AD8734Q50078274-C697CD98-E88F-40EA-85CE-7F939C9D96E4Q52312436-068D8647-D2A4-477C-93A8-7B75EC4AA050
P2860
Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Primary Double-Strike Therapy ...... ance: Proposal from the Bench.
@en
type
label
Primary Double-Strike Therapy ...... ance: Proposal from the Bench.
@en
prefLabel
Primary Double-Strike Therapy ...... ance: Proposal from the Bench.
@en
P2093
P2860
P1476
Primary Double-Strike Therapy ...... ance: Proposal from the Bench.
@en
P2093
Christopher J Rivard
Fred R Hirsch
Paul A Bunn
Tetsuya Mitsudomi
P2860
P356
10.1016/J.JTHO.2016.09.003
P50
P577
2016-09-15T00:00:00Z